On the importance of electrostatic interactions between cell penetrating peptides and membranes: A pathway toward tumor cell selectivity?

Biochimie

Volumn 107, Issue Part A, 2014, Pages 154-159

  Jobin, Marie Lise ^a   Alves, Isabel D ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Cell penetrating peptides; Electrostatic interactions; Peptide lipid interactions; Tumor cell specificity

Indexed keywords

ARGININE; CANCER ANTIBODY; CELL PENETRATING PEPTIDE; DOXORUBICIN; GLYCOSAMINOGLYCAN; HEPSIN; INTERLEUKIN 13; LIPOSOME; MEMBRANE LIPID; NANOPARTICLE; TRANSACTIVATOR PROTEIN; PROTEIN BINDING;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; BREAST CANCER; CELL HOMING; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; CELL SPECIFICITY; CELL SURFACE; CELL TYPE; COLON CANCER; CYTOTOXICITY; DRUG DELIVERY SYSTEM; GLIOBLASTOMA; GLIOMA CELL LINE; HUMAN; INTERNALIZATION; LUNG CANCER; MELANOMA CELL; MEMBRANE COMPONENT; NEUROBLASTOMA; NONHUMAN; PROTEIN LIPID INTERACTION; SQUAMOUS CELL CARCINOMA; STATIC ELECTRICITY; TUMOR CELL; TUMOR XENOGRAFT; BIOLOGICAL MODEL; CHEMISTRY; METABOLISM; MOLECULAR GENETICS; NEOPLASM; PATHOLOGY;

AMINO ACID SEQUENCE; ARGININE; CELL MEMBRANE; CELL-PENETRATING PEPTIDES; HUMANS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; NEOPLASMS; PROTEIN BINDING; STATIC ELECTRICITY;

EID: 84915817769     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2014.07.022     Document Type: Short Survey

References (74)

1. G.P. Dietz, and M. Bahr Delivery of bioactive molecules into the cell: the Trojan horse approach Mol. Cell. Neurosci. 27 2004 85 131
2. S. Deshayes, M.C. Morris, G. Divita, and F. Heitz Cell-penetrating peptides: tools for intracellular delivery of therapeutics Cell. Mol. Life Sci. 62 2005 1839 1849
3. E. Vives Present and future of cell-penetrating peptide mediated delivery systems: "is the Trojan horse too wild to go only to Troy?" J. Control. Release 109 2005 77 85
4. E. Vives, P. Brodin, and B. Lebleu A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus J. Biol. Chem. 272 1997 16010 16017
5. M. Bernfield, M. Gotte, P.W. Park, O. Reizes, M.L. Fitzgerald, J. Lincecum, and M. Zako Functions of cell surface heparan sulfate proteoglycans Annu. Rev. Biochem. 68 1999 729 777
6. I.D. Alves, C.Y. Jiao, S. Aubry, B. Aussedat, F. Burlina, G. Chassaing, and S. Sagan Cell biology meets biophysics to unveil the different mechanisms of penetratin internalization in cells Biochim. Biophys. Acta 1798 2010 2231 2239
7. C. Bechara, and S. Sagan Cell-penetrating peptides: 20 years later, where do we stand? FEBS Lett. 587 2013 1693 1702
8. M.L. Jobin, P. Bonnafous, H. Temsamani, F. Dole, A. Grelard, E.J. Dufourc, and I.D. Alves The enhanced membrane interaction and perturbation of a cell penetrating peptide in the presence of anionic lipids: toward an understanding of its selectivity for cancer cells Biochim. Biophys. Acta 1828 2013 1457 1470
9. P. Wadhwani, R.F. Epand, N. Heidenreich, J. Burck, A.S. Ulrich, and R.M. Epand Membrane-active peptides and the clustering of anionic lipids Biophys. J. 103 2012 265 274
10. A. Ziegler, and J. Seelig Contributions of glycosaminoglycan binding and clustering to the biological uptake of the nonamphipathic cell-penetrating peptide WR9 Biochemistry 50 2011 4650 4664
11. I.R. de Figueiredo, J.M. Freire, L. Flores, A.S. Veiga, and M.A. Castanho Cell-penetrating peptides: a tool for effective delivery in gene-targeted therapies IUBMB Life 66 3 2014 182 194
12. X. Lin, and N. Perrimon Role of heparan sulfate proteoglycans in cell-cell signaling in Drosophila Matrix Biol. 19 2000 303 307
13. F.H. Blackhall, C.L. Merry, E.J. Davies, and G.C. Jayson Heparan sulfate proteoglycans and cancer Br. J. Cancer 85 2001 1094 1098
14. E.H. Knelson, J.C. Nee, and G.C. Blobe Heparan sulfate signaling in cancer Trends Biochem. Sci. 39 6 2014 277 288
15. D. Derossi, S. Calvet, A. Trembleau, A. Brunissen, G. Chassaing, and A. Prochiantz Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent J. Biol. Chem. 271 1996 18188 18193
16. F. Duchardt, M. Fotin-Mleczek, H. Schwarz, R. Fischer, and R. Brock A comprehensive model for the cellular uptake of cationic cell-penetrating peptides Traffic 8 2007 848 866
17. S. El Andaloussi, P. Guterstam, and U. Langel Assessing the delivery efficacy and internalization route of cell-penetrating peptides Nat. Protoc. 2 2007 2043 2047
18. H. Binder, and G. Lindblom Charge-dependent translocation of the Trojan peptide penetratin across lipid membranes Biophys. J. 85 2003 982 995
19. C.Y. Jiao, D. Delaroche, F. Burlina, I.D. Alves, G. Chassaing, and S. Sagan Translocation and endocytosis for cell-penetrating peptide internalization J. Biol. Chem. 284 2009 33957 33965
20. I.D. Alves, A. Walrant, C. Bechara, and S. Sagan Is there anybody in there? On the mechanisms of wall crossing of cell penetrating peptides Curr. Protein Pept. Sci. 13 2012 658 671
21. E. Vives Cellular uptake [correction of utake] of the Tat peptide: an endocytosis mechanism following ionic interactions J. Mol. Recognit. 16 2003 265 271
22. H.J. Ryser, and R. Hancock Histones and basic polyamino acids stimulate the uptake of albumin by tumor cells in culture Science 150 1965 501 503
23. M. Belting Heparan sulfate proteoglycan as a plasma membrane carrier Trends Biochem Sci. 28 2003 145 151
24. I. Nakase, A. Tadokoro, N. Kawabata, T. Takeuchi, H. Katoh, K. Hiramoto, M. Negishi, M. Nomizu, Y. Sugiura, and S. Futaki Interaction of arginine-rich peptides with membrane-associated proteoglycans is crucial for induction of actin organization and macropinocytosis Biochemistry 46 2007 492 501
25. A. Walrant, I. Correia, C.Y. Jiao, O. Lequin, E.H. Bent, N. Goasdoue, C. Lacombe, G. Chassaing, S. Sagan, and I.D. Alves Different membrane behaviour and cellular uptake of three basic arginine-rich peptides Biochim. Biophys. Acta 1808 2011 382 393
26. P. Lecorche, A. Walrant, F. Burlina, L. Dutot, S. Sagan, J.M. Mallet, B. Desbat, G. Chassaing, I.D. Alves, and S. Lavielle Cellular uptake and biophysical properties of galactose and/or tryptophan containing cell-penetrating peptides Biochim. Biophys. Acta 1818 2012 448 457
27. N. Afratis, C. Gialeli, D. Nikitovic, T. Tsegenidis, E. Karousou, A.D. Theocharis, M.S. Pavao, G.N. Tzanakakis, and N.K. Karamanos Glycosaminoglycans: key players in cancer cell biology and treatment FEBS J. 279 2012 1177 1197
28. K. Matsuda, H. Maruyama, F. Guo, J. Kleeff, J. Itakura, Y. Matsumoto, A.D. Lander, and M. Korc Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells Cancer Res. 61 2001 5562 5569
29. D. Nikitovic, M. Mytilinaiou, A. Berdiaki, N.K. Karamanos, and G.N. Tzanakakis Heparan sulfate proteoglycans and heparin regulate melanoma cell functions Biochim. Biophys. Acta 1840 8 2014 2471 2481
30. G. Chalkiadaki, D. Nikitovic, A. Berdiaki, M. Sifaki, K. Krasagakis, P. Katonis, N.K. Karamanos, and G.N. Tzanakakis Fibroblast growth factor-2 modulates melanoma adhesion and migration through a syndecan-4-dependent mechanism Int. J. Biochem. Cell Biol. 41 2009 1323 1331
31. S.I. Zittermann, M.I. Capurro, W. Shi, and J. Filmus Soluble glypican 3 inhibits the growth of hepatocellular carcinoma in vitro and in vivo Int. J. Cancer 126 2010 1291 1301
32. J.H. Lee, H. Park, H. Chung, S. Choi, Y. Kim, H. Yoo, T.Y. Kim, H.J. Hann, I. Seong, J. Kim, K.G. Kang, I.O. Han, and E.S. Oh Syndecan-2 regulates the migratory potential of melanoma cells J. Biol. Chem. 284 2009 27167 27175
33. R.D. Sanderson Heparan sulfate proteoglycans in invasion and metastasis Semin. Cell Dev. Biol. 12 2001 89 98
34. I. Vlodavsky, O. Goldshmidt, E. Zcharia, R. Atzmon, Z. Rangini-Guatta, M. Elkin, T. Peretz, and Y. Friedmann Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development Semin. Cancer Biol. 12 2002 121 129
35. C. Bechara, M. Pallerla, Y. Zaltsman, F. Burlina, I.D. Alves, O. Lequin, and S. Sagan Tryptophan within basic peptide sequences triggers glycosaminoglycan-dependent endocytosis FASEB J. 27 2013 738 749
36. S. Deshayes, T. Plenat, G. Aldrian-Herrada, G. Divita, C. Le Grimellec, and F. Heitz Primary amphipathic cell-penetrating peptides: structural requirements and interactions with model membranes Biochemistry 43 2004 7698 7706
37. A. Walrant, A. Vogel, I. Correia, O. Lequin, B.E. Olausson, B. Desbat, S. Sagan, and I.D. Alves Membrane interactions of two arginine-rich peptides with different cell internalization capacities Biochim. Biophys. Acta 1818 2012 1755 1763
38. A.B. Hendrich, and K. Michalak Lipids as a target for drugs modulating multidrug resistance of cancer cells Curr. Drug Targets 4 2003 23 30
39. B. Frey, and U.S. Gaipl The immune functions of phosphatidylserine in membranes of dying cells and microvesicles Semin. Immunopathol. 33 2011 497 516
40. S. Ran, A. Downes, and P.E. Thorpe Increased exposure of anionic phospholipids on the surface of tumor blood vessels Cancer Res. 62 2002 6132 6140
41. J. Connor, C. Bucana, I.J. Fidler, and A.J. Schroit Differentiation-dependent expression of phosphatidylserine in mammalian plasma membranes: quantitative assessment of outer-leaflet lipid by prothrombinase complex formation Proc. Natl. Acad. Sci. U. S. A. 86 1989 3184 3188
42. T. Utsugi, A.J. Schroit, J. Connor, C.D. Bucana, and I.J. Fidler Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes Cancer Res. 51 1991 3062 3066
43. M. Sok, M. Sentjurc, and M. Schara Membrane fluidity characteristics of human lung cancer Cancer Lett. 139 1999 215 220
44. S. Futaki, T. Suzuki, W. Ohashi, T. Yagami, S. Tanaka, K. Ueda, and Y. Sugiura Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery J. Biol. Chem. 276 2001 5836 5840
45. D.J. Mitchell, D.T. Kim, L. Steinman, C.G. Fathman, and J.B. Rothbard Polyarginine enters cells more efficiently than other polycationic homopolymers J. Pept. Res. 56 2000 318 325
46. P.A. Wender, D.J. Mitchell, K. Pattabiraman, E.T. Pelkey, L. Steinman, and J.B. Rothbard The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters Proc. Natl. Acad. Sci. U. S. A. 97 2000 13003 13008
47. P.M. Fischer, N.Z. Zhelev, S. Wang, J.E. Melville, R. Fahraeus, and D.P. Lane Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin J. Pept. Res. 55 2000 163 172
48. H.L. Amand, H.A. Rydberg, L.H. Fornander, P. Lincoln, B. Norden, and E.K. Esbjorner Cell surface binding and uptake of arginine- and lysine-rich penetratin peptides in absence and presence of proteoglycans Biochim. Biophys. Acta 1818 2012 2669 2678
49. M. Nishihara, F. Perret, T. Takeuchi, S. Futaki, A.N. Lazar, A.W. Coleman, N. Sakai, and S. Matile Arginine magic with new counterions up the sleeve Org. Biomol. Chem. 3 2005 1659 1669
50. N. Sakai, T. Takeuchi, S. Futaki, and S. Matile Direct observation of anion-mediated translocation of fluorescent oligoarginine carriers into and across bulk liquid and anionic bilayer membranes Chembiochem 6 2005 114 122
51. A. Mishra, V.D. Gordon, L. Yang, R. Coridan, and G.C. Wong HIV TAT forms pores in membranes by inducing saddle-splay curvature: potential role of bidentate hydrogen bonding Angew. Chem. Int. Ed. Engl. 47 2008 2986 2989
52. J.B. Rothbard, T.C. Jessop, and P.A. Wender Adaptive translocation: the role of hydrogen bonding and membrane potential in the uptake of guanidinium-rich transporters into cells Adv. Drug Deliv. Rev. 57 2005 495 504
53. J.M. Gump, R.K. June, and S.F. Dowdy Revised role of glycosaminoglycans in TAT protein transduction domain-mediated cellular transduction J. Biol. Chem. 285 2010 1500 1507
54. M. Hyvonen, J. Enback, T. Huhtala, J. Lammi, H. Sihto, J. Weisell, H. Joensuu, K. Rosenthal-Aizman, S. El-Andaloussi, U. Langel, A. Narvanen, G. Bergers, and P. Laakkonen Novel target for peptide-based imaging and treatment of brain tumors Mol. Cancer Ther. 13 2014 996 1007
55. M.H. Kang, M.J. Park, H.J. Yoo, K.Y. Hyuk, S.G. Lee, S.R. Kim, D.W. Yeom, M.J. Kang, and Y.W. Choi RIPL peptide (IPLVVPLRRRRRRRRC)-conjugated liposomes for enhanced intracellular drug delivery to hepsin-expressing cancer cells Eur. J. Pharm. Biopharm. 87 3 2014 489 499
56. V.P. Torchilin Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers Adv. Drug Deliv. Rev. 60 2008 548 558
57. D.C. Anderson, E. Nichols, R. Manger, D. Woodle, M. Barry, and A.R. Fritzberg Tumor cell retention of antibody Fab fragments is enhanced by an attached HIV TAT protein-derived peptide Biochem. Biophys. Res. Commun. 194 1993 876 884
58. M.M. Fretz, G.A. Koning, E. Mastrobattista, W. Jiskoot, and G. Storm OVCAR-3 cells internalize TAT-peptide modified liposomes by endocytosis Biochim. Biophys. Acta 1665 2004 48 56
59. C. Marty, C. Meylan, H. Schott, K. Ballmer-Hofer, and R.A. Schwendener Enhanced heparan sulfate proteoglycan-mediated uptake of cell-penetrating peptide-modified liposomes Cell. Mol. Life Sci. 61 2004 1785 1794
60. S. Wang, N.Z. Zhelev, S. Duff, and P.M. Fischer Synthesis and biological activity of conjugates between paclitaxel and the cell delivery vector penetratin Bioorg. Med. Chem. Lett. 16 2006 2628 2631
61. M. Jain, S.C. Chauhan, A.P. Singh, G. Venkatraman, D. Colcher, and S.K. Batra Penetratin improves tumor retention of single-chain antibodies: a novel step toward optimization of radioimmunotherapy of solid tumors Cancer Res. 65 2005 7840 7846
62. I.D. Alves, M. Carre, M.P. Montero, S. Castano, S. Lecomte, R. Marquant, P. Lecorche, F. Burlina, C. Schatz, S. Sagan, G. Chassaing, D. Braguer, and S. Lavielle A proapoptotic peptide conjugated to penetratin selectively inhibits tumor cell growth Biochim. Biophys. Acta 1838 2014 2087 2098
63. E. Eriste, K. Kurrikoff, J. Suhorutsenko, N. Oskolkov, D.M. Copolovici, S. Jones, P. Laakkonen, J. Howl, and U. Langel Peptide-based glioma-targeted drug delivery vector gHoPe2 Bioconjug. Chem. 24 2013 305 313
64. I. Nakase, Y. Konishi, M. Ueda, H. Saji, and S. Futaki Accumulation of arginine-rich cell-penetrating peptides in tumors and the potential for anticancer drug delivery in vivo J. Control. Release 159 2012 181 188
65. Y.L. Tseng, J.J. Liu, and R.L. Hong Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and tat: a kinetic and efficacy study Mol. Pharmacol. 62 2002 864 872
66. E. Koren, A. Apte, A. Jani, and V.P. Torchilin Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity J. Control. Release 160 2012 264 273
67. G. Tunnemann, R.M. Martin, S. Haupt, C. Patsch, F. Edenhofer, and M.C. Cardoso Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells FASEB J. 20 2006 1775 1784
68. J.R. Maiolo, M. Ferrer, and E.A. Ottinger Effects of cargo molecules on the cellular uptake of arginine-rich cell-penetrating peptides Biochim. Biophys. Acta 1712 2005 161 172
69. M.E. Favretto, R. Wallbrecher, S. Schmidt, R. van de Putte, and R. Brock Glycosaminoglycans in the cellular uptake of drug delivery vectors - bystanders or active players? J. Control. Release 180 2014 81 90
70. A. Ziegler, and J. Seelig Binding and clustering of glycosaminoglycans: a common property of mono- and multivalent cell-penetrating compounds Biophys. J. 94 2008 2142 2149
71. D. Delaroche, F.X. Cantrelle, F. Subra, C. Van Heijenoort, E. Guittet, C.Y. Jiao, L. Blanchoin, G. Chassaing, S. Lavielle, C. Auclair, and S. Sagan Cell-penetrating peptides with intracellular actin-remodeling activity in malignant fibroblasts J. Biol. Chem. 285 2010 7712 7721
72. E. Kondo, K. Saito, Y. Tashiro, K. Kamide, S. Uno, T. Furuya, M. Mashita, K. Nakajima, T. Tsumuraya, N. Kobayashi, M. Nishibori, M. Tanimoto, and M. Matsushita Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems Nat. Commun. 3 2012 951
73. S. Richter, V. Bouvet, M. Wuest, R. Bergmann, J. Steinbach, J. Pietzsch, I. Neundorf, and F. Wuest (18)F-Labeled phosphopeptide-cell-penetrating peptide dimers with enhanced cell uptake properties in human cancer cells Nucl. Med. Biol. 39 2012 1202 1212
74. A. Mishra, G.H. Lai, N.W. Schmidt, V.Z. Sun, A.R. Rodriguez, R. Tong, L. Tang, J. Cheng, T.J. Deming, D.T. Kamei, and G.C. Wong Translocation of HIV TAT peptide and analogues induced by multiplexed membrane and cytoskeletal interactions Proc. Natl. Acad. Sci. U. S. A. 108 2011 16883 16888.